Riccardo Dondolin, Dr

Division of Hematology, Department of Translational Medicine, Università Del Piemonte Orientale, Italy

NA

Poster(s):

• 1007 - XPO1 mutations identify early stage CLL characterized by shorter time to first treatment and enhanced BCR signaling